What is ErgoSuture?
ErgoSuture is a medical device innovator focused on revolutionizing surgical procedures with its Roller-Based Suturing (RBS) platform. This technology is engineered to enhance safety, speed, and versatility in suturing, proving particularly beneficial for complex operations such as laparoscopic and robotic surgeries. By significantly reducing suturing time and improving surgeon proficiency, ErgoSuture aims to elevate surgical care standards across various specialties, including general, bariatric, and cardiovascular surgery. The company is actively pursuing global expansion and broadening its product portfolio.
How much funding has ErgoSuture raised?
ErgoSuture has raised a total of $3.2M across 1 funding round:
Angel/Seed
$3.2M
Angel/Seed (2020): $3.2M, investors not publicly disclosed
What's next for ErgoSuture?
The recent major strategic investment signals a pivotal growth phase for ErgoSuture, likely enabling the company to scale its operations, accelerate product development, and expand its market reach. This infusion of capital is expected to support further innovation in surgical suturing technology and solidify ErgoSuture's position as a key player in the medical device industry. The company's focus on enhancing surgeon capabilities and patient outcomes positions it for continued advancement and adoption within the surgical community.
See full ErgoSuture company page
